Scancell Holdings plc SCNLF
1.18 USD 0.00 (+0.00%)
Nov 2, 2026, 9:30 AM EST
1.18 Day range 1.18
0.141 52-week range 3.35
- YTD
- -35.16%
- 1 year
- -35.16%
- Market cap
- 143.04M
- EPS (ttm)
- -0.01
- P/E ratio
- -118.00
- YTD return
- -35.16%
- 1-year return
- -35.16%
- Volume
- 3.10K
- Avg volume
- 495
- Open
- 1.18
- Previous close
- 1.18
- Day's range
- 1.18 – 1.18
- 52-week range
- 0.141 – 3.35
2Y -0.64 (-35.16%)
News
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial 
Scancell Holdings secures $25m financing as it advances melanoma trial 
Cancer vaccine breakthrough at Moderna raises hopes for Scancell's melanoma programme 
Marvell shares jump as Google warrant deepens AI chip partnership 
Scancell secures UK clearance for late-stage melanoma trial 
Ford and GM upgraded by Jefferies on improving outlooks, stronger cash generation 
Chip stocks slide as China advances domestic lithography, memory production 
Scancell sees high demand in retail share offer, seals £15.7m from UK investors 
SMALL-CAP MOVERS: Nasdaq-bound Scancell catches the eye as AIM's headcount falls to 612 
American Airlines shares fall as fuel costs weigh on third-quarter outlook despite earnings beat
Your note
Sign in to keep a note on SCNLF — it syncs with the Stock Master app.